|
1
|
Chowdhury FA, Hossain MK, Mostofa AGM,
Akbor MM and Bin Sayeed MS: Therapeutic potential of thymoquinone
in glioblastoma treatment: Targeting major gliomagenesis signaling
pathways. Biomed Res Int. 2018:40106292018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ostrom QT, Gittleman H, Truitt G, Boscia
A, Kruchko C and Barnholtz-Sloan JS: CBTRUS statistical report:
Primary brain and other central nervous system tumors diagnosed in
the United States in 2011–2015. Neuro Oncol. 20 (Suppl 4):iv1–iv86.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Dewitt JC, Mock A and Louis DN: The 2016
WHO classification of central nervous system tumors: What
neurologists need to know. Curr Opin Neurol. 30:643–649. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Walker AE, Robins M and Weinfeld FD:
Epidemiology of brain tumors The national survey of intracranial
neoplasms. Neurology. 35:219–226. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Amankulor NM, Kim Y, Arora S, Kargl J,
Szulzewsky F, Hanke M, Margineantu DH, Rao A, Bolouri H, Delrow J,
et al: Mutant IDH1 regulates the tumor-associated immune system in
gliomas. Genes Dev. 31:774–786. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Venur VA, Peereboom DM and Ahluwalia MS:
Current medical treatment of glioblastoma. Cancer Treat Res.
163:103–115. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kang JH and Adamson C: Novel
chemotherapeutics and other therapies for treating high-grade
glioma. Expert Opin Investig Drugs. 24:1361–1379. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shannon K, Koehne W, Heyman MB and Koerper
MA: Relapsing post-hepatitis aplastic anemia. Immunosuppressive
therapy. Clin Pediatr (Phila). 29:25–29. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Giraldo NA, Becht E, Remark R, Damotte D,
Sautès-Fridman C and Fridman WH: The immune contexture of primary
and metastatic human tumour. Curr Opin Immunol. 27:8–15. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim R, Emi M and Tanabe K: Cancer
immunoediting from immune surveillance to immune escape.
Immunology. 121:1–14. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Finocchiaro G and Pellegatta S:
Immunotherapy for glioma: Getting closer to the clinical arena?
Curr Opin Neurol. 24:641–647. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Borisov KE and Sakaeva DD: The
immunosuppressive microenvironment of malignant gliomas. Arkh
Patol. 77:54–63. 2015.(In Russian). View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu J, Lichtenberg T, Hoadley KA, Poisson
LM, Lazar AJ, Cherniack AD, Kovatich AJ, Benz CC, Levine DA, Lee
AV, et al: Abstract 3287: An integrated TCGA pan-cancer clinical
data resource to drive high quality survival outcome analytics.
Cancer Res. 78 (Suppl 13):S32872018.
|
|
14
|
Kawaguchi A, Yajima N, Tsuchiya N, Homma
J, Sano M, Natsumeda M, Takahashi H, Fujii Y, Kakuma T and Yamanaka
R: Gene expression signature-based prognostic risk score in
patients with glioblastoma. Cancer Sci. 104:1205–1210. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bhattacharya S, Andorf S, Gomes L, Dunn P,
Schaefer H, Pontius J, Berger P, Desborough V, Smith T, Campbell J,
et al: ImmPort: Disseminating data to the public for the future of
immunology. Immunol Res. 58:234–239. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Macklaim JM, Fernandes AD, Di Bella JM,
Hammond JA, Reid G and Gloor GB: Comparative meta-RNA-seq of the
vaginal microbiota and differential expression by
Lactobacillus iners in health and dysbiosis. Microbiome.
1:122013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee S, Han S, Ju HS, Kim SY, Won HJ, Shin
YM, Kim PN, An J, Lee D, Kim KM, et al: A patient-based nomogram
for predicting overall survival after radiofrequency ablation for
hepatocellular carcinoma. J Vasc Interv Radiol. 26:1787–1794.e1.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zeelen C, Paus C, Draper D, Heskamp S,
Signore A, Galli F, Griessinger CM and Aarntzen EH: In-vivo imaging
of tumor-infiltrating immune cells: Implications for cancer
immunotherapy. Q J Nucl Med Mol Imaging. 62:56–77. 2018.PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ivliev AE, ‘t Hoen PA and Sergeeva MG:
Coexpression network analysis identifies transcriptional modules
related to proastrocytic differentiation and sprouty signaling in
glioma. Cancer Res. 70:10060–10070. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang J, Bu X, Wang H, Zhu Y, Geng Y,
Nihira NT, Tan Y, Ci Y, Wu F, Dai X, et al: Cyclin D-CDK4 kinase
destabilizes PD-L1 via cullin 3-SPOP to control cancer immune
surveillance. Nature. 553:91–95. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Scimè A, Li L, Ciavarra G and Whyte P:
Cyclin D1/cdk4 can interact with E2F4/DP1 and disrupts its
DNA-binding capacity. J Cell Physiol. 214:568–581. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dean JL, Mcclendon AK, Hickey TE, Butler
LM, Tilley WD, Witkiewicz AK and Knudsen ES: Therapeutic response
to CDK4/6 inhibition in breast cancer defined by ex vivo analyses
of human tumors. Cell Cycle. 11:2756–2761. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Silber J, Lim DA, Petritsch C, Persson AI,
Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello
JF, et al: miR-124 and miR-137 inhibit proliferation of
glioblastoma multiforme cells and induce differentiation of brain
tumor stem cells. BMC Med. 6:142008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Szöcs K, Lassègue B, Sorescu D, Hilenski
LL, Valppu L, Couse TL, Wilcox JN, Quinn MT, Lambeth JD and
Griendling KK: Upregulation of Nox-based NAD(P)H oxidases in
restenosis after carotid injury. Arterioscler Thromb Vasc Biol.
22:21–27. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li Y, Han N, Yin T, Huang L, Liu S, Liu D,
Xie C and Zhang M: Lentivirus-mediated Nox4 shRNA invasion and
angiogenesis and enhances radiosensitivity in human glioblastoma.
Oxid Med Cell Longev. 2014:5817322014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Gressot LV, Doucette T, Yang Y, Fuller GN,
Manyam G, Rao A, Latha K and Rao G: Analysis of the inhibitors of
apoptosis identifies BIRC3 as a facilitator of malignant
progression in glioma. Oncotarget. 8:12695–12704. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhao H, Zhang X, Han Z, Wang Z and Wang Y:
Plasma anti-BIRC5 IgG may be a useful marker for evaluating the
prognosis of nonsmall cell lung cancer. Febs Open Bio. 8:829–835.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang H, Geng D, Gao J, Qi Y, Shi Y, Wang
Y, Jiang Y, Zhang Y, Fu J, Dong Y, et al: Expression and
significance of Hippo/YAP signaling in glioma progression. Tumour
Biol. 37:15665–15676. 2016. View Article : Google Scholar
|
|
30
|
Ma YF, Ren Y, Wu CJ, Zhao XH, Xu H, Wu DZ,
Xu J, Zhang XL and Ji Y: Interleukin (IL)-24 transforms the tumor
microenvironment and induces anticancer immunity in a murine model
of colon cancer. Mol Immunol. 75:11–20. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Nagakawa H, Shimozato O, Yu L, Wada A,
Kawamura K, Li Q, Chada S, Tada Y, Takiguchi Y, Tatsumi K and
Tagawa M: Expression of a murine homolog of apoptosis-inducing
human IL-24/MDA-7 in murine tumors fails to induce apoptosis or
produce anti-tumor effects. Cell Immunol. 275:90–97. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhou A, Lin K, Zhang S, Chen Y, Zhang N,
Xue J, Wang Z, Aldape KD, Xie K, Woodgett JR and Huang S: Nuclear
GSK3β promotes tumorigenesis by phosphorylating KDM1A and inducing
its deubiquitylation by USP22. Nat Cell Biol. 18:954–966. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang X, Li D, Cheng S, Fan K, Sheng L,
Zhang J, Feng B and Xu Z: The correlation of bone morphogenetic
protein 2 with poor prognosis in glioma patients. Tumour Biol.
35:11091–11095. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hollinger DM and Rossiter RJ: Chemical
studies of peripheral nerve during wallerian degeneration. V.
B-Glucuronidase. Biochem J. 52:659–663. 1952. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tong L, Yi L, Liu P, Abeysekera IR, Hai L,
Li T, Tao Z, Ma H, Xie Y, Huang Y, et al: Tumour cell dormancy as a
contributor to the reduced survival of GBM patients who received
standard therapy. Oncol Rep. 40:463–471. 2018.PubMed/NCBI
|
|
36
|
Nijaguna MB, Patil V, Hegde AS,
Chandramouli BA, Arivazhagan A, Santosh V and Somasundaram K: An
eighteen serum cytokine signature for discriminating glioma from
normal healthy individuals. PLoS One. 10:e01375242015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhou L, Tang H, Wang F, Chen L, Ou S, Wu
T, Xu J and Guo K: Bioinformatics analyses of significant genes,
related pathways and candidate prognostic biomarkers in
glioblastoma. Mol Med Rep. 18:4185–4196. 2018.PubMed/NCBI
|
|
38
|
Pal J, Patil V, Kumar A, Kaur K, Sarkar C
and Somasundaram K: Loss-of-function mutations in Calcitonin
receptor (CALCR) identify highly aggressive glioblastoma with poor
outcome. Clin Cancer Res. 24:1448–1458. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Reon BJ, Anaya J, Zhang Y, Mandell J,
Purow B, Abounader R and Dutta A: Expression of lncRNAs in
low-grade gliomas and glioblastoma multiforme: An in silico
analysis. PLoS Med. 13:e10021922016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Li M and Yu XQ: Genetic determinants of
IgA nephropathy: Eastern perspective. Semin Nephrol. 38:455–460.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Feagan BG, Schreiber S, Wolf DC, Axler JL,
Kaviya A, James A, Curtis RI, Geransar P, Stallmach A, Ehehalt R,
et al: Sustained clinical remission with vedolizumab in patients
with moderate-to-severe ulcerative colitis. Inflamm Bowel Dis.
25:1028–1035. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Magistroni R, D'Agati VD, Appel GB and
Kiryluk K: New developments in the genetics, pathogenesis, and
therapy of IgA nephropathy. Kidney Int. 88:974–989. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chen X, Zang W, Xue F, Shen Z and Zhang Q:
Bioinformatics analysis reveals potential candidate drugs for
different subtypes of glioma. Neurol Sci. 34:1139–1143. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Fu H, Ge B, Chen D, Wu Y, Luo Q, Li X,
Zheng C and Tang Q: Phytanoyl-CoA 2-hydroxylase-interacting
protein-like gene is a therapeutic target gene for glioblastoma
multiforme. Med Sci Monit. 25:2583–2590. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hussain M, Shah Z, Abbas N, Javeed A,
Mukhtar MM and Zhang J: Targeting tumor-associated immune
suppression with selective protein kinase A type I (PKAI)
inhibitors may enhance cancer immunotherapy. Med Hypotheses.
86:56–59. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Sang W, Wang Y, Zhang C, Zhang D, Sun C,
Niu M, Zhang Z, Wei X, Pan B, Chen W, et al: MiR-150 impairs
inflammatory cytokine production by targeting ARRB-2 after blocking
CD28/B7 costimulatory pathway. Immunol Lett. 172:1–10. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lv P, Wang W, Cao Z, Zhao D, Zhao G, Li D,
Qi L and Xu J: Fsk and IBMX inhibit proliferation and proapoptotic
of glioma stem cells via activation of cAMP signaling pathway. J
Cell Biochem. 120:321–331. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Daniel PM, Filiz G and Mantamadiotis T:
Sensitivity of GBM cells to cAMP agonist-mediated apoptosis
correlates with CD44 expression and agonist resistance with MAPK
signaling. Cell Death Dis. 7:e24942016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Han SJ, Zygourakis C, Lim M and Parsa AT:
Immunotherapy for glioma: Promises and challenges. Neurosurg Clin N
Am. 23:357–370. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Bullard DE, Gillespie GY, Mahaley MS and
Bigner DD: Immunobiology of human glioma. Semin Oncol. 13:94–109.
1986.PubMed/NCBI
|
|
51
|
Winfield JB: Role of phagocytosis in
macrophage function in an in vitro primary immune system. Cell
Immunol. 2:690–695. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Mantovani A, Marchesi F, Malesci A, Laghi
L and Allavena P: Tumour-associated macrophages as treatment
targets in oncology. Nat Rev Clin Oncol. 14:399–416. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Choi J, Gyamfi J, Jang H and Koo JS: The
role of tumor-associated macrophage in breast cancer biology.
Histol Histopathol. 33:133–145. 2018.PubMed/NCBI
|
|
54
|
Yin J, Valin KL, Dixon ML and Leavenworth
JW: The role of microglia and macrophages in CNS homeostasis,
autoimmunity, and cancer. J Immunol Res. 2017:51506782017.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Abediankenari S, Janbabaei Mollae G,
Ghasemi M, Yousefzadeh Y, Bahrami M and Alimoghaddam K: Vaccination
of diffuse large B-cell lymphoma patients with antigen-primed
dendritic cells. Acta Med Iran. 51:284–288. 2013.PubMed/NCBI
|
|
56
|
Gardner A and Ruffell B: Dendritic cells
and cancer immunity. Trends Immunol. 37:855–865. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Steinman RM and Banchereau J: Taking
dendritic cells into medicine. Nature. 449:419–426. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Wang JZ, Zhang YH, Guo XH, Zhang HY and
Zhang Y: The double-edge role of B cells in mediating antitumor
T-cell immunity: Pharmacological strategies for cancer
immunotherapy. Int Immunopharmacol. 36:73–85. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Seifert M and Küppers R: Human memory B
cells. Leukemia. 30:2283–2292. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Ahrén B, Taborsky GJ Jr and Porte D Jr:
Neuropeptidergic versus cholinergic and adrenergic regulation of
islet hormone secretion. Diabetologia. 29:827–836. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Liang W and Ferrara N: The complex role of
neutrophils in tumor angiogenesis and metastasis. Cancer Immunol
Res. 4:83–91. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Massara M, Persico P, Bonavita O, Mollica
Poeta V, Locati M, Simonelli M and Bonecchi R: Neutrophils in
gliomas. Front Immunol. 8:13492017. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Ocana A, Nieto-Jiménez C, Pandiella A and
Templeton AJ: Neutrophils in cancer: Prognostic role and
therapeutic strategies. Mol Cancer. 16:1372017. View Article : Google Scholar : PubMed/NCBI
|
